Trans-scleral drug delivery method and apparatus

Details Trans-scleral drug delivery method and apparatus Trans-scleral drug delivery method and apparatus

2007-10-02

2007-10-02

Sirmons, Kevin C. (Department: 3767)

Surgery

Means for introducing or removing material from body for...

Treating material applied to or removed from external...

C604S521000, C424S427000

Reexamination Certificate

active

10791487

ABSTRACT:
A method of treating ocular disorders involving angiogenesis includes the steps of providing a trans-scleral drug delivery device comprising an insert stabilizer for attachment to a scleral surface and having an interlock opening and a replaceable implant having a reservoir adjacent the scleral surface and an interlock tab, wherein said insert stabilizer and said replaceable implant are removeably connectable by mating said interlock tab and said interlock opening; providing an anti-angiogenic factor; introducing said anti-angiogenic factor into said reservoir; and attaching said insert stabilizer to the scleral surface. The reservoir can be refilled by disengaging the implant from the stabilizer, inserting a new dosage of anti-angiogenic factor, and reconnecting the implant to the stabilizer or injecting a new dosage of anti-angiogenic factor into the reservoir through an injection port in the stabilizer.

REFERENCES:
patent: 4590201 (1986-05-01), Bochis et al.
patent: 5098443 (1992-03-01), Parel et al.
patent: 5132315 (1992-07-01), Kohn et al.
patent: 5177074 (1993-01-01), Allen et al.
patent: 5177095 (1993-01-01), Greenlee et al.
patent: 5187179 (1993-02-01), Ashton et al.
patent: 5234917 (1993-08-01), Finkelstein et al.
patent: 5300114 (1994-04-01), Gwon et al.
patent: 5488050 (1996-01-01), Neufeld
patent: 5602156 (1997-02-01), Kohn et al.
patent: 5744492 (1998-04-01), Kohn et al.
patent: 6126687 (2000-10-01), Peyman
patent: 6239137 (2001-05-01), Karmali et al.
patent: 6413540 (2002-07-01), Yaacobi
patent: 6416777 (2002-07-01), Yaacobi
patent: 6420399 (2002-07-01), Graff et al.
patent: 6599910 (2003-07-01), Adams et al.
patent: 2002/0010176 (2002-01-01), Askew et al.
patent: 2002/0086862 (2002-07-01), Baxter et al.
patent: 2002/0183365 (2002-12-01), Wagle et al.
patent: 2002/0188282 (2002-12-01), Greenberg
patent: 2003/0013712 (2003-01-01), Tullis et al.
patent: 2003/0014036 (2003-01-01), Varner et al.
patent: 2003/0100558 (2003-05-01), Tullis et al.
patent: 2003/0114416 (2003-06-01), Pulaski et al.
patent: 2003/0125361 (2003-07-01), Clare et al.
patent: 2003/0143199 (2003-07-01), Carson et al.
patent: 2003/0149051 (2003-08-01), Green et al.
patent: 2004/0198829 (2004-10-01), Sponsel et al.
patent: 2005/0113806 (2005-05-01), De Carvalho et al.
patent: 2275866 (1990-11-01), None

Affiliated with

Also associated with

Rating

Trans-scleral drug delivery method and apparatus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Trans-scleral drug delivery method and apparatus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Trans-scleral drug delivery method and apparatus will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3901888